Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.134 5 days ( -1.94 % )
Last Price $126.66 -1.66 %
High/ Low $126.53 - $129.68 9.97%
Chg 7 Days 8.15 % $117.12 $126.66
Chg 30 Days -2.16 % $129.46 $126.66
Chg 12 mos 1.24 % $125.11 $126.66
Trend - 3 mos -3.88 % Width: 19.65 %
Trend - 12 mos -1.77 % Width: 113.59 %
Pred. range - 3 mos $110.54 - $132.26 -12.73 % - 4.42 %
Pred. range - 12 mos $64.88 - $138.59 -48.77 % - 9.42 %
Short MA avg 3 mos Buy Apr 22, 2024 - 7 days
Long MA avg 3 mos Buy Apr 23, 2024 - 6 days
Short/Long MA avg 3 mos Sell Apr 04, 2024 - 19 days
Short MA avg 12 mos Buy Apr 23, 2024 - 6 days
Long MA avg 12 mos Buy Jan 08, 2024 - 79 days
Short/Long MA avg 12 mos Buy Jan 18, 2024 - 72 days
Pivot Short Sell Apr 29, 2024 - 2 days
Bollinger Buy Apr 19, 2024 - 8 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Sarepta Therapeutics

Sarepta Therapeutics Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of ... SRPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT